MDMA Rapid Drug Test

Product Description

The MDMA Rapid Drug Test is a qualitative immunoassay designed for the rapid detection of 3,4-methylenedioxymethamphetamine (MDMA) in human urine. This point-of-care test provides a quick and convenient method for screening individuals for the presence of MDMA, a common recreational drug. Results are obtained within minutes, allowing for timely decision-making in various settings. The test is intended for use by trained personnel and should be used in conjunction with other clinical evaluations for definitive diagnosis. The test utilizes a specific antibody to detect MDMA metabolites in the urine sample, offering a high level of specificity to reduce false positive results. This assay is valuable in clinical toxicology, forensic investigations, and workplace drug screening programs.

Features

Rapid results (5-10 minutes)
Easy-to-use, visually interpretable format
Point-of-care suitable

Specifications

Parameter	Specification
Detection Target	MDMA (3,4-methylenedioxymethamphetamine) metabolites
Sample Type	Urine
Methodology	Immunochromatography
Detection Range	Positive/Negative
Reaction Time	5-10 minutes
Storage Conditions	2-30°C
Shelf Life	18 months

Product Advantages

Early Screening Tool

Helps quickly identify infected individuals, implement timely isolation measures, and control the spread of the epidemic.

Suitable for Multiple Scenarios

Suitable for various scenarios such as home self-testing, corporate screening, schools, and clinics.

Reliable Quality

Strict quality control system ensures stable and reliable product performance.

Instructions for Use

Read the instructions carefully.
Prepare sample collection tools and the test kit.
Collect the sample according to the instructions.
Add the sample to the test cassette.
Wait 15 minutes to read the results.

Certification Information

CE Certified
ISO13485

Interested in MDMA Rapid Drug Test?

Back to Products Request Quote